Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation.
Rev Endocr Metab Disord. 2020 Dec;21(4):431-447. doi: 10.1007/s11154-020-09584-3. Epub 2020 Aug 26.
Rev Endocr Metab Disord. 2020.
PMID: 32851581
Review.